Rang	Name	Position
1	Mr. Alan H. Auerbach	Founder, Chairman, President, CEO & Secretary
2	Mr. Maximo F. Nougues	CFO & Principal Accounting Officer
3	Mr. Douglas Hunt B.Sc., FRAPS	Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer
4	Mr. Gordon G. Esplin	Chief Accounting Officer
5	Mr. Mariann Ohanesian	Senior Director of Investor Relations
6	Ms. Heather Blaber	Senior Vice President of Marketing
7	Mr. Roger L. Storms	Senior Vice President of Sales
8	Ms. Pamela Wilson BA	Senior Vice President of Clinical Operations
9	Dr. Petra Rietschel	Senior Vice President of Clinical Development
10	Mr. Kenneth Wiehe	Senior Vice President of Supply Chain & Manufacturing

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	6,97%	32,82 Mio. USD
2	American Century Companies Inc	4,49%	21,16 Mio. USD
3	Acadian Asset Management LLC	3,96%	18,62 Mio. USD
4	Renaissance Technologies Corp	3,76%	17,72 Mio. USD
5	Vanguard Capital Management, LLC	3,52%	16,58 Mio. USD
6	Vanguard Portfolio Management, LLC	3,36%	15,82 Mio. USD
7	LSV Asset Management	3,13%	14,76 Mio. USD
8	Dimensional Fund Advisors, Inc.	2,94%	13,84 Mio. USD
9	O'Shaughnessy Asset Management LLC	2,20%	10,38 Mio. USD
10	Geode Capital Management, LLC	1,97%	9,28 Mio. USD
11	State Street Corp	1,78%	8,37 Mio. USD
12	Kennedy Capital Management Inc	1,69%	7,96 Mio. USD
13	AQR Capital Management LLC	1,55%	7,30 Mio. USD
14	Connor Clark & Lunn Inv Mgmt Ltd	1,52%	7,14 Mio. USD
15	Bridgeway Capital Management, LLC	1,50%	7,07 Mio. USD
16	Comprehensive Portfolio Management, LLC	1,45%	6,84 Mio. USD
17	The Goldman Sachs Group Inc	1,30%	6,11 Mio. USD
18	Northern Trust Corp	1,24%	5,85 Mio. USD
19	Millennium Management LLC	1,17%	5,49 Mio. USD
20	Arrowstreet Capital Limited Partnership	1,04%	4,91 Mio. USD